000 01378 a2200373 4500
005 20250515224220.0
264 0 _c20101008
008 201010s 0 0 ger d
022 _a1435-1250
024 7 _a10.1007/s00393-010-0612-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGause, A
245 0 0 _a[Recommendations of the German rheumatology society on the use of tocilizumab in rheumatoid arthritis].
_h[electronic resource]
260 _bZeitschrift fur Rheumatologie
_cJun 2010
300 _a365-72 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntibodies, Monoclonal
_xadministration & dosage
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aAntirheumatic Agents
_xadministration & dosage
650 0 4 _aArthritis, Rheumatoid
_xdrug therapy
650 0 4 _aDelivery of Health Care
_xstandards
650 0 4 _aGermany
650 0 4 _aGuideline Adherence
_xstandards
650 0 4 _aGuidelines as Topic
_xstandards
650 0 4 _aHumans
650 0 4 _aQuality Assurance, Health Care
_xstandards
650 0 4 _aRheumatology
_xstandards
700 1 _aRubbert-Roth, A
700 1 _aMichels, H
700 1 _aGaubitz, M
700 1 _aMayet, W-J
773 0 _tZeitschrift fur Rheumatologie
_gvol. 69
_gno. 4
_gp. 365-72
856 4 0 _uhttps://doi.org/10.1007/s00393-010-0612-6
_zAvailable from publisher's website
999 _c19848913
_d19848913